Ness R, Handelsman L, Aronson M J, Hershkowitz A, Kanof P D
Psychiatry Service, Veterans Affairs Medical Center, Bronx, New York 10468.
J Nerv Ment Dis. 1994 Jun;182(6):353-9. doi: 10.1097/00005053-199406000-00008.
Self-reported dysphoria, personality disorder traits, and subjective opioid withdrawal symptoms were assessed in 30 opioid abusers before and after a rapid medical detoxification from heroin. Subject exclusion criteria reflected an effort to control for potential sources of affective change that were extraneous to the effect of detoxification. Subjects received few rehabilitative services during their 12-day inpatient hospitalization, and were not permitted visitors or off-ward privileges. At the preadmission assessment, they reported elevated levels of dysphoria and personality disorder traits, as well as opioid withdrawal symptoms. The results indicate that clinically significant declines in symptoms of dysphoria, opioid withdrawal symptoms, and personality disorder traits occur during the course of a rapid medical detoxification. Dysphoric and opioid withdrawal symptom abatement was most pronounced between the preadmission and admission assessments. These factors should be considered in the clinical diagnosis and treatment, as well as in research about psychiatric comorbidity of these substance abusers.
在30名阿片类药物滥用者进行海洛因快速医学脱毒治疗前后,对其自我报告的烦躁不安、人格障碍特质和主观阿片类药物戒断症状进行了评估。受试者排除标准旨在控制与脱毒效果无关的潜在情感变化来源。受试者在为期12天的住院治疗期间接受的康复服务很少,且不允许访客探视或离院特权。在入院前评估中,他们报告了较高水平的烦躁不安、人格障碍特质以及阿片类药物戒断症状。结果表明,在快速医学脱毒过程中,烦躁不安症状、阿片类药物戒断症状和人格障碍特质出现了临床上显著的下降。烦躁不安和阿片类药物戒断症状的减轻在入院前和入院评估之间最为明显。在这些药物滥用者的临床诊断和治疗以及精神共病研究中应考虑这些因素。